The Association of the British Pharmaceutical Industry (ABPI) and the BioIndustry Association (BIA) have welcomed the publication of the first case study showcasing the guidance MHRA can provide to pharmaceutical companies, looking to invest in the UK.Read more
Research by the ABPI published today (20 November) shows that 90% of clinicians and other health professionals surveyed believe that stratified medicine – particularly non-cancer applications – will have a positive impact on the health system in the UK.Read more
ABPI Chief Executive, Stephen Whitehead, comments on the announcement by the Government of a new initiative to accelerate access for NHS patients to new medical innovations and a review of the pathway for development assessment and adoption of 21st Century medicines, devices and diagnostics.Read more
As the ABPI launches its latest research showing significant barriers to the NHS accessing life-saving and life-enhancing stratified medicines, ABPI Chief Executive Stephen Whitehead considers why the Government’s new Innovative Medicines and MedTech Review into the pathway for development, assessment and adoption of 21st Century medical innovation couldn’t be better timed. Read more
Our website is currently experiencing scrolling issues when viewed using Internet Explorer 8. If you are experiencing problems with scrolling please upgrade to a later version of Internet Explorer or use Chrome or Firefox.
Board of Management